2,560
Views
29
CrossRef citations to date
0
Altmetric
Editorial

Malaria vaccine based on self-assembling protein nanoparticles

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matthew B. Laurens. (2021) Novel malaria vaccines. Human Vaccines & Immunotherapeutics 17:11, pages 4549-4552.
Read now
Kiat Hwa Chan, Wei Hao Lee, Shuangmu Zhuo & Ming Ni. (2017) Harnessing supramolecular peptide nanotechnology in biomedical applications. International Journal of Nanomedicine 12, pages 1171-1182.
Read now

Articles from other publishers (27)

Ming Xia, Pengwei Huang, Frank Vago, Wen Jiang & Ming Tan. (2023) Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody. Vaccines 11:11, pages 1650.
Crossref
Chittaranjan Baruah, Pankaj Das, Papari Devi, Palash Moni Saikia & Bhabesh Deka. (2023) The emergence of nanovaccines as a new paradigm in virological vaccinology: a review. Exploration of Immunology, pages 361-383.
Crossref
Kun Chen, Ming Jiang, Jin Liu, Deli Huang & Yuhe R. Yang. (2023) DNA nanostructures as biomolecular scaffolds for antigen display . WIREs Nanomedicine and Nanobiotechnology.
Crossref
Faizan Zarreen Simnani, Dibyangshee Singh, Paritosh Patel, Anmol Choudhury, Adrija Sinha, Aditya Nandi, Shailesh Kumar Samal, Suresh K. Verma & Pritam Kumar Panda. (2023) Nanocarrier vaccine therapeutics for global infectious and chronic diseases. Materials Today 66, pages 371-408.
Crossref
Andrew P. Hederman & Margaret E. Ackerman. (2023) Leveraging deep learning to improve vaccine design. Trends in Immunology 44:5, pages 333-344.
Crossref
Piyali Dey, Somasree Ray & Pronobesh Chattopadhyay. 2023. Design and Applications of Theranostic Nanomedicines. Design and Applications of Theranostic Nanomedicines 345 366 .
Farhad Zahedi, Akram Abouie Mehrizi, Soroush Sardari & Iran Alemzadeh. (2022) Design and development of a self-assembling protein nanoparticle displaying PfHAP2 antigenic determinants recognized by natural acquired antibodies. PLOS ONE 17:9, pages e0274275.
Crossref
Dan Wang, Linwei Duan, Min Wei, Baizhu Chen, Zhipeng Li & Qingyou Liu. (2022) Establishment of a soluble expression and rapid purification system for self-assembling protein nanoparticle and characterization of its physiochemical properties. Biochemical Engineering Journal 186, pages 108580.
Crossref
Cosette G. Schneider, Julien Fey, Xiaoyan Zou, Vince Gerbasi, Tatyana Savransky, Carl Batt, Elke Bergmann-Leitner & Evelina Angov. (2022) Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection. Vaccine 40:31, pages 4270-4280.
Crossref
Shikha Jha, Rohitas Deshmukh & Vishal Trivedi. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 149 172 .
Maria Tsakiri, Nikolaos Naziris & Costas Demetzos. (2021) Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic. International Journal of Pharmaceutics 610, pages 121212.
Crossref
Sakineh Pirahmadi, Shima Afzali, Mostafa Zargar, Sedigheh Zakeri & Akram Abouie Mehrizi. (2021) How can we develop an effective subunit vaccine to achieve successful malaria eradication?. Microbial Pathogenesis 160, pages 105203.
Crossref
Mahdi Ftouh, Nesrine Kalboussi, Nabil Abid, Souad Sfar, Nathalie Mignet & Badr Bahloul. (2021) Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses. PPAR Research 2021, pages 1-28.
Crossref
. 2021. Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II). Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II) 194 245 .
Cosette G. Schneider, Justin A. Taylor, Michael Q. Sibilo, Kazutoyo Miura, Katherine L. Mallory, Christopher Mann, Christopher Karch, Zoltan Beck, Gary R. Matyas, Carole A. Long, Elke Bergmann-Leitner, Peter Burkhard & Evelina Angov. (2021) Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity. Vaccines 9:2, pages 103.
Crossref
Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn & Vesna Blazevic. (2020) Internalization and antigen presentation by mouse dendritic cells of rotavirus VP6 preparations differing in nanostructure. Molecular Immunology 123, pages 26-31.
Crossref
Hesam Dorosti, Mahboobeh Eslami, Navid Nezafat, Fardin Fadaei & Younes Ghasemi. (2019) Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: An in silico strategy. Molecular and Cellular Probes 48, pages 101446.
Crossref
Priya Katyal, Michael Meleties & Jin K. Montclare. (2019) Self-Assembled Protein- and Peptide-Based Nanomaterials. ACS Biomaterials Science & Engineering 5:9, pages 4132-4147.
Crossref
Manisha Pritam, Garima Singh, Suchit Swaroop, Akhilesh Kumar Singh & Satarudra Prakash Singh. (2019) Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum. BMC Bioinformatics 19:S13.
Crossref
Barney S. GrahamMorgan S.A. GilmanJason S. McLellan. (2019) Structure-Based Vaccine Antigen Design. Annual Review of Medicine 70:1, pages 91-104.
Crossref
Adrian Najer, Cornelia G. Palivan, Hans-Peter Beck & Wolfgang Meier. 2018. Infectious Diseases and Nanomedicine III. Infectious Diseases and Nanomedicine III 103 112 .
Christopher P. Karch, Tais A. P. F. Doll, Sara M. Paulillo, Issa Nebie, David E. Lanar, Giampietro Corradin & Peter Burkhard. (2017) The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria. Journal of Nanobiotechnology 15:1.
Crossref
Kamal El Bissati, Ying Zhou, Sara Maria Paulillo, Senthil Kumar Raman, Christopher P. Karch, Craig W. Roberts, David E. Lanar, Steve Reed, Chris Fox, Darrick Carter, Jeff Alexander, Alessandro Sette, John Sidney, Hernan Lorenzi, Ian J. Begeman, Peter Burkhard & Rima McLeod. (2017) Protein nanovaccine confers robust immunity against Toxoplasma. npj Vaccines 2:1.
Crossref
Eva Torres-Sangiao, Alina Holban & Monica Gestal. (2016) Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases. Molecules 21:7, pages 867.
Crossref
Kathryn M Frietze, David S Peabody & Bryce Chackerian. (2016) Engineering virus-like particles as vaccine platforms. Current Opinion in Virology 18, pages 44-49.
Crossref
Hinojal Zazo, Clara I. Colino & José M. Lanao. (2016) Current applications of nanoparticles in infectious diseases. Journal of Controlled Release 224, pages 86-102.
Crossref
Olukemi O. Ifeonu, Raphael Simon, Sharon M. Tennant, Abhineet S. Sheoran, Maria C. Daly, Victor Felix, Jessica C. Kissinger, Giovanni Widmer, Myron M. Levine, Saul Tzipori & Joana C. Silva. (2016) Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates . Database 2016, pages baw137.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.